Seven firms gave K2M shares a consensus recommendation of "buy," according to web breaking news.
Here are five facts:
1. The shares have an average one-year price target of $25.50.
2. K2M Director Carlos A. Ferrer purchased 38,924 company shares for a total value of nearly $500,015.
3. Dr. Ferrer currently owns 39,383 K2M shares.
4. On April 26, K2M shares opened at $16.75.
5. The market cap is $690.57 million.
More device news:
Wenzel Spine's VariLift-LX on full US commercial launch: 5 key notes
4th patient in INSPIRE study experiences AIS grade improvement: 5 things to know
Life Spine to host physician workshop for new solutions launching in 2016 — 3 highlights